1. Home
  2. SAMG vs CNTX Comparison

SAMG vs CNTX Comparison

Compare SAMG & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

N/A

Current Price

$14.90

Market Cap

125.5M

Sector

Finance

ML Signal

N/A

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

N/A

Current Price

$3.17

Market Cap

209.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SAMG
CNTX
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.5M
209.5M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SAMG
CNTX
Price
$14.90
$3.17
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$6.00
AVG Volume (30 Days)
17.8K
909.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.71%
N/A
EPS Growth
N/A
69.33
EPS
0.55
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
$3.37
N/A
Revenue Next Year
$10.62
N/A
P/E Ratio
$26.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.23
$0.49
52 Week High
$17.28
$3.30

Technical Indicators

Market Signals
Indicator
SAMG
CNTX
Relative Strength Index (RSI) 43.00 70.48
Support Level $14.47 $2.07
Resistance Level $15.50 N/A
Average True Range (ATR) 0.42 0.24
MACD -0.06 0.06
Stochastic Oscillator 44.84 89.75

Price Performance

Historical Comparison
SAMG
CNTX

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: